M.L. Richard Yip - Concepedia

Concepedia

Author

M.L. Richard Yip

City Of Hope National Medical Center ORCID

Also Known As

M. L. Richard Yip, M.L. Richard Yip, Yip, M.L.R.

42

Publications

1.7K

Citations

14

H-Index

29

Concepts

All Affiliations

City Of Hope National Medical Center City of Hope Cancer Center of Hawaii Beckman Research Institute University of South Florida

MR

About

M.L. Richard Yip is an author at City Of Hope National Medical Center specializing in medicine, natural sciences, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	292
2	Natural Sciences	3	3	154
3	Cell Biology	3	3	265
4	Biochemistry	2	2	50
5	Biology	2	2	127

M.L. Richard Yip

×

14

Publications

1.7K

Citations

14

H-Index

	Year	Citations
Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity Khandaker Siddiquee, Shumin Zhang, Wayne C. Guida, Proceedings of the National Academy of Sciences	2007	738
Discovery of a Novel Shp2 Protein Tyrosine Phosphatase Inhibitor Liwei Chen, Shen‐Shu Sung, M.L. Richard Yip, Molecular Pharmacology	2006	274
Control of germ-band retraction in <i>Drosophila</i> by the zinc-finger protein HINDSIGHT M.L. Richard Yip, Michele L. Lamka, Howard D. Lipshitz Development GeneticsMolecular GeneticsEmbryologyRetraction ProcessGerm Cell Development	1997	104
Inhibitors of Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (Shp2) Based on Oxindole Scaffolds Harshani R. Lawrence, Roberta Pireddu, Liwei Chen, Journal of Medicinal Chemistry	2008	94
Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells Yujun Wang, Ernest Han, Quanhua Xing, Cancer Letters Tumor BiologyMtor InhibitionMedicinePharmacologyCancer Cell Biology	2014	91
A Small-Molecule Blocking Ribonucleotide Reductase Holoenzyme Formation Inhibits Cancer Cell Growth and Overcomes Drug Resistance Bingsen Zhou, Leila Su, Shuya Hu, Cancer Research	2013	80
Identification of Oct4-activating compounds that enhance reprogramming efficiency Wendong Li, Erpo Tian, Zhaoxia Chen, Proceedings of the National Academy of Sciences	2012	73
Identification of Anti-Malarial Compounds as Novel Antagonists to Chemokine Receptor CXCR4 in Pancreatic Cancer Cells Joseph Kim, M.L. Richard Yip, Xiaoming Shen, PLoS ONE Chemoprevention StrategyCxcr4-mediated SignalingImmunologyPancreatic Cancer CellsTumor Biology	2012	70
CCR9‐mediated signaling through β‐catenin and identification of a novel CCR9 antagonist Sangjun Lee, Eileen L. Heinrich, Lily Li, Molecular Oncology	2015	28
Identification of a disruptor of the MDM2-p53 protein–protein interaction facilitated by high-throughput in silico docking Harshani R. Lawrence, Zhenyu Li, M.L. Richard Yip, Bioorganic & Medicinal Chemistry Letters BiochemistryProtein FoldingMedicineNatural SciencesBiomolecular Analysis	2009	27

Page 1